Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$68.93 USD
+0.18 (0.26%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $68.93 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 31% (77 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.27 | 1.67 | 9.99 |
Current Quarter Estimate | 0.68 | 4.86 | 61.00 |
Year Ago Quarter Estimate | 0.59 | 3.59 | 54.84 |
Next Quarter Estimate | 0.68 | 5.65 | 63.00 |
Next Year Estimate | 2.79 | 24.58 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 7.57 | 12.90 | 15.67 |
Next Year | 3.33 | 21.40 | 11.34 |
Last 5 Years | 9.90 | 10.20 | 8.10 |
Next 5 Years | 8.90 | 13.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 26.61 | 7.86 |
Price/Book (MRQ) | 5.53 | 2.38 |
Price/Cash Flow (MRFY) | 24.95 | 19.29 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 24.55% | -28.30% |
Return on Equity (TTM) | 22.35% | -24.58% |
Debt to Equity (MRQ) | 0.08 | 7.85 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.